多肽CRDMO平台
目录肽
大奖888生化目录肽版块全新呈现，致力于打造全球最全面的多肽供应平台！我们专业的学术团队将时刻追踪最新最热的研究动向，帮助您发现实际需求，并以最高质量标准提供您所需要的产品。我们将我们将不定期更新产品列表，为您最大限度地节约科研时间，敬请广大客户朋友关注！
CASP-089B
Decanoyl-Arg-Val-Lys-Arg-chloromethylketone
Decy-Arg-Val-Lys-Arg-CMK
Decy-Arg-Val-Lys-Arg-CMK
Size：1.0
P1(RMB)：860
MW：744.4
One letter sequence：Decy-RVKR-CMK
Molecular Formula：C34H66ClN11O5
Description：Peptidyl chloromethylketone that binds to the catalytic site of furin and thus inhibits cleavage and fusion activity of viral glycoproteins, as well as virus replication. This compound also decreases the production of b-amyloid-induced active matrix metalloproteinase 2 in U87 cells. Furthermore, other than furin N-1505 the protein also inhibited the proprotein convertases PC7/LPC, PACE4, and PC6 (W.Garten, personal communication). \r\n
Literature Reference：W.Garten et al., Virology , 172, 25 (1989)\r\n\r\nA.Stieneke-Gr?ber et al., EMBO J. , 11, 2407 (1992)\r\n\r\nS.Hallenberger et al., Nature , 360, 358 (1992)\r\n\r\nW.Garten et al., Biochimie , 76, 217 (1994)\r\n\r\nJ.-B.Denault et al., FEBS Lett. , 362, 276 (1995)\r\n\r\nJ.-B.Denault et al., J. Cardiovasc. Pharmacol. , 26 (Suppl.3), S47 (1995)\r\n\r\nS.Hallenberger et al., J. Virol. , 71, 1036 (1997)\r\n\r\nS.Deb et al., J. Neurosci. Res. , 55, 44 (1999)\r\n
Cas：[ 150113-99-8
P1(RMB)：860
MW：744.4
One letter sequence：Decy-RVKR-CMK
Molecular Formula：C34H66ClN11O5
Description：Peptidyl chloromethylketone that binds to the catalytic site of furin and thus inhibits cleavage and fusion activity of viral glycoproteins, as well as virus replication. This compound also decreases the production of b-amyloid-induced active matrix metalloproteinase 2 in U87 cells. Furthermore, other than furin N-1505 the protein also inhibited the proprotein convertases PC7/LPC, PACE4, and PC6 (W.Garten, personal communication). \r\n
Literature Reference：W.Garten et al., Virology , 172, 25 (1989)\r\n\r\nA.Stieneke-Gr?ber et al., EMBO J. , 11, 2407 (1992)\r\n\r\nS.Hallenberger et al., Nature , 360, 358 (1992)\r\n\r\nW.Garten et al., Biochimie , 76, 217 (1994)\r\n\r\nJ.-B.Denault et al., FEBS Lett. , 362, 276 (1995)\r\n\r\nJ.-B.Denault et al., J. Cardiovasc. Pharmacol. , 26 (Suppl.3), S47 (1995)\r\n\r\nS.Hallenberger et al., J. Virol. , 71, 1036 (1997)\r\n\r\nS.Deb et al., J. Neurosci. Res. , 55, 44 (1999)\r\n
Cas：[ 150113-99-8
